Scivanta Medical (SCVM) and SeaSpine (SPNE) Critical Contrast

Scivanta Medical (OTCMKTS:SCVM) and SeaSpine (NASDAQ:SPNE) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, institutional ownership and valuation.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Scivanta Medical and SeaSpine, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Scivanta Medical 0 0 0 0 N/A
SeaSpine 0 0 5 0 3.00

SeaSpine has a consensus target price of $19.40, suggesting a potential upside of 11.69%. Given SeaSpine’s higher possible upside, analysts clearly believe SeaSpine is more favorable than Scivanta Medical.

Insider & Institutional Ownership

53.4% of SeaSpine shares are owned by institutional investors. 34.0% of Scivanta Medical shares are owned by insiders. Comparatively, 13.5% of SeaSpine shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Risk and Volatility

Scivanta Medical has a beta of 0.98, meaning that its share price is 2% less volatile than the S&P 500. Comparatively, SeaSpine has a beta of 0.46, meaning that its share price is 54% less volatile than the S&P 500.

Profitability

This table compares Scivanta Medical and SeaSpine’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Scivanta Medical N/A N/A N/A
SeaSpine -21.75% -27.65% -21.65%

Valuation & Earnings

This table compares Scivanta Medical and SeaSpine’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Scivanta Medical N/A N/A -$300,000.00 N/A N/A
SeaSpine $131.81 million 1.94 -$32.11 million ($2.58) -6.73

Scivanta Medical has higher earnings, but lower revenue than SeaSpine.

Summary

Scivanta Medical beats SeaSpine on 6 of the 10 factors compared between the two stocks.

Scivanta Medical Company Profile

Scivanta Medical Corporation does not have significant operations. Previously, it was engaged in the development, manufacture, and distribution of the Scivanta cardiac monitoring system. The company intends to acquire a new technology, product, or service. The company was formerly known as Medi-Hut Co., Inc. The company was founded in 1981 and is headquartered in Spring Lake, New Jersey.

SeaSpine Company Profile

SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. The company provides orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical regions of the spine. Its orthobiologics products include demineralized bone matrices, collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to enhance bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures. The company offers orthobiologics products in various forms, such as putties, pastes, strips, and resorbable mesh. Its spinal implant portfolio comprises products for spinal decompression, alignment, and stabilization that are used to facilitate fusion in minimally invasive, complex, deformity, and degenerative procedures. The company was incorporated in 2015 and is headquartered in Carlsbad, California.

Receive News & Ratings for Scivanta Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scivanta Medical and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply